ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013